The maintenance of an Equal-Weight rating and a steady price target by a major analyst like Morgan Stanley suggests a neutral outlook on Endava's stock in the short term. This indicates that the analyst sees the company's current valuation as fair and does not anticipate significant price movement in either direction based on current information.